COVID-19 vaccine–induced immunity is less robust in PLHIV, especially for persons with low CD4+ T-cell counts or unsuppressed viremia (20–25), but our results indicate that this deficit is likely not linked to cross-reactive prepandemic responses. The gene discussed is CD4; the disease is COVID-19.